BBNS logo

The Latest Headlines at BBNS

Image about Analysts Set World Kinect Co. (NYSE:WKC) Target Price at $26.75

Analysts Set World Kinect Co. (NYSE:WKC) Target Price at $26.75

World Kinect Co. (NYSE:WKC – Get Free Report) has received a consensus recommendation of “Hold” from the four research firms that are currently covering the company, Marketbeat reports. One investment analyst has... More of this article »
Image about Pembina Pipeline (NYSE:PBA) Raised to “Buy” at StockNews.com

Pembina Pipeline (NYSE:PBA) Raised to “Buy” at StockNews.com

StockNews.com upgraded shares of Pembina Pipeline (NYSE:PBA – Free Report) (TSE:PPL) from a hold rating to a buy rating in a report released on Friday morning. Separately, TheStreet raised shares of Pembina Pipeline from a c... More of this article »
Image about Ashford (NYSE:AINC) Research Coverage Started at StockNews.com

Ashford (NYSE:AINC) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Ashford (NYSE:AINC – Free Report) in a report released on Friday. The firm issued a buy rating on the stock. Ashford Stock Performance AINC opened at $4.98 on Friday. Ashford has a one... More of this article »
Image about Chicago Rivet & Machine (NYSEAMERICAN:CVR) Research Coverage Started at StockNews.com

Chicago Rivet & Machine (NYSEAMERICAN:CVR) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Chicago Rivet & Machine (NYSEAMERICAN:CVR – Free Report) in a research note published on Friday. The firm issued a sell rating on the stock. Chicago Rivet & Machine Stock... More of this article »
Image about StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)

StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)

StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Friday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Shares... More of this article »
Image about Mobileye Global (NASDAQ:MBLY) Upgraded by Wolfe Research to Outperform

Mobileye Global (NASDAQ:MBLY) Upgraded by Wolfe Research to Outperform

Wolfe Research upgraded shares of Mobileye Global (NASDAQ:MBLY – Free Report) from a peer perform rating to an outperform rating in a report published on Friday, MarketBeat Ratings reports. Wolfe Research currently has $41.00... More of this article »
Image about Evotec (NASDAQ:EVO) Upgraded to Buy by Deutsche Bank Aktiengesellschaft

Evotec (NASDAQ:EVO) Upgraded to Buy by Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft upgraded shares of Evotec (NASDAQ:EVO – Free Report) from a hold rating to a buy rating in a research report report published on Friday morning, MarketBeat reports. Separately, Royal Bank of Canada... More of this article »
Image about Ligand Pharmaceuticals (NASDAQ:LGND) Rating Reiterated by Benchmark

Ligand Pharmaceuticals (NASDAQ:LGND) Rating Reiterated by Benchmark

Benchmark reissued their buy rating on shares of Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) in a report published on Friday, Benzinga reports. The firm currently has a $95.00 price target on the biotechnology company’s... More of this article »
Image about Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) Downgraded to Hold at StockNews.com

Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) Downgraded to Hold at StockNews.com

StockNews.com cut shares of Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK – Free Report) from a buy rating to a hold rating in a report published on Friday. Perusahaan Perseroan (Persero) PT Telekomunikasi... More of this article »
Image about The Goldman Sachs Group Increases Travelers Companies (NYSE:TRV) Price Target to $212.00

The Goldman Sachs Group Increases Travelers Companies (NYSE:TRV) Price Target to $212.00

Travelers Companies (NYSE:TRV – Free Report) had its price target boosted by The Goldman Sachs Group from $186.00 to $212.00 in a report published on Friday, Benzinga reports. The firm currently has a sell rating on the insurance... More of this article »
Image about China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report released on Friday. The brokerage issued a hold rating on the stock. China Pharma Trading Down 3.8 % Shares of CPHI opened at $0.36... More of this article »
Image about The Goldman Sachs Group Increases The Hartford Financial Services Group (NYSE:HIG) Price Target to $105.00

The Goldman Sachs Group Increases The Hartford Financial Services Group (NYSE:HIG) Price Target to $105.00

The Hartford Financial Services Group (NYSE:HIG – Free Report) had its target price lifted by The Goldman Sachs Group from $92.00 to $105.00 in a research note issued to investors on Friday morning, Benzinga reports. The brokerage... More of this article »
Image about WK Kellogg (NYSE:KLG) Price Target Raised to $15.00 at Barclays

WK Kellogg (NYSE:KLG) Price Target Raised to $15.00 at Barclays

WK Kellogg (NYSE:KLG – Free Report) had its price objective boosted by Barclays from $12.00 to $15.00 in a report published on Friday morning, Benzinga reports. The firm currently has an underweight rating on the stock. Several... More of this article »
Image about Franklin BSP Realty Trust (NYSE:FBRT) Stock Rating Upgraded by Raymond James

Franklin BSP Realty Trust (NYSE:FBRT) Stock Rating Upgraded by Raymond James

Raymond James upgraded shares of Franklin BSP Realty Trust (NYSE:FBRT – Free Report) from an outperform rating to a strong-buy rating in a research note issued to investors on Friday, Marketbeat reports. Raymond James currently... More of this article »
Image about Constellation Brands (NYSE:STZ) Price Target Raised to $315.00 at BMO Capital Markets

Constellation Brands (NYSE:STZ) Price Target Raised to $315.00 at BMO Capital Markets

Constellation Brands (NYSE:STZ – Free Report) had its target price increased by BMO Capital Markets from $290.00 to $315.00 in a research note released on Friday, Benzinga reports. BMO Capital Markets currently has an outperform... More of this article »